Literature DB >> 9627642

Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.

G O Naumann1, U Schlötzer-Schrehardt, M Küchle.   

Abstract

BACKGROUND: Renewed interest in pseudoexfoliation syndrome (PEX) may be attributed to an increased awareness of many clinical risks not only for open-angle glaucoma and its recent recognition as a generalized disorder. This review summarizes the range of intraocular and extraocular manifestations. Involvement of all tissues of the anterior segment of the eye results in a spectrum of intraocular complications that have management implication for all practicing ophthalmologists.
DESIGN: The study design was a review.
METHODS: Clinical diagnosis depends on biomicroscopy, biocytology, and laser-tyndallometry. Laboratory research methods range from light and electron microscopy, to immunohistochemical and molecular biologic approaches. OBSERVATIONS: Clinical-histopathologic correlations focus on the involvement of lens (PEX-phacopathy), zonular apparatus (zonulopathy), ciliary body (cyclopathy), iris (iridopathy), trabecular meshwork (trabeculopathy), and cornea (corneal endotheliopathy) leading to the following complications: (1) open-angle glaucoma as well as angle-closure glaucoma due to pupillary and ciliary block; (2) phacodonesis, lens dislocation, and increased incidence of vitreous loss in extracapsular cataract surgery caused by alterations of the zonular apparatus and its insertion into the ciliary body and lens; (3) blood-aqueous barrier breakdown (pseudouveitis), anterior chamber hypoxia, iris stromal hemorrhage, pigment epithelial melanin dispersion, poor or asymmetric pupillary dilatation, and formation of posterior synechiae due to involvement of all cell populations of the iris; and (4) early diffuse corneal endothelial decompensation explained by a damaged and numerically reduced endothelium.
CONCLUSIONS: In view of the multitude of clinical complications, PEX is of relevance to comprehensive ophthalmologists, including specialists in glaucoma, cataract, cornea, neuro-ophthalmology, and retina. Special attention to the risks associated with PEX is advised before, during, and after surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9627642     DOI: 10.1016/S0161-6420(98)96020-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  99 in total

1.  Effects of early postoperative complications and the location of trephined block on long-term intraocular pressure control after trabeculectomy.

Authors:  Pia Ehrnrooth; Ilkka Lehto; Päivi Puska; Leila Laatikainen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-29       Impact factor: 3.117

2.  Occurrence of capsular delamination in the dislocated in-the-bag intraocular lens.

Authors:  Akira Hirata; Satoshi Okinami; Ken Hayashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-06       Impact factor: 3.117

3.  Cerebrovascular blood flow velocities in pseudoexfoliation.

Authors:  Nurşen Yüksel; Yonca Anik; Aysun Kiliç; Vlevent Karabaş; Ali Demirci; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-13       Impact factor: 3.117

4.  Exfoliation and carotid stiffness.

Authors:  M Irkec
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

5.  Effect of a capsular tension ring on prevention of intraocular lens decentration and tilt and on anterior capsule contraction after cataract surgery.

Authors:  Anselm Jünemann; Ursula Schlötzer-Schrehardt; Gottfried O H Naumann
Journal:  Jpn J Ophthalmol       Date:  2009-05       Impact factor: 2.447

6.  Late in-the-bag intraocular lens dislocation requiring explantation: risk factors and outcomes.

Authors:  R Fernández-Buenaga; J L Alio; A L Pérez-Ardoy; A Larrosa-Quesada; L Pinilla-Cortés; R Barraquer; J L Alio; F J Muñoz-Negrete
Journal:  Eye (Lond)       Date:  2013-06-14       Impact factor: 3.775

7.  Aqueous humour levels of ghrelin in exfoliation syndrome and exfoliation glaucoma patients.

Authors:  Ayşe Vural Ozeç; Ayhan Dursun; Mustafa Ilker Toker; Yüksel Demirci; Aysen Topalkara; Haydar Erdoğan; Mustafa Kemal Arıcı; Taner Ersalcan
Journal:  Jpn J Ophthalmol       Date:  2014-05-08       Impact factor: 2.447

8.  Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome.

Authors:  Sabina Janciauskiene; Torsten Krakau
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

9.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

10.  Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population.

Authors:  Ling Chen; Liyun Jia; Ningli Wang; Guangxian Tang; Chun Zhang; Sujie Fan; Wenru Liu; Hailin Meng; Wotan Zeng; Ningpu Liu; Huaizhou Wang; Hongyan Jia
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.